Imunon, Inc. (IMNN) vs Liminatus Pharma, Inc. Class A Common Stock (LIMN)

A side-by-side comparison of Imunon, Inc. and Liminatus Pharma, Inc. Class A Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Imunon, Inc. logo
IMNN
Imunon, Inc.
$5M
$1.24HealthcareDelayed quote: Oct 6, 2026, 10:23 AM EDT
Liminatus Pharma, Inc. Class A Common Stock logo
LIMN
Liminatus Pharma, Inc. Class A Common Stock
$5M
$3.88HealthcareDelayed quote: Oct 6, 2026, 10:20 AM EDT

Total return — IMNN vs LIMN

growth of $100 · dividends reinvested · last 1y
IMNN -90.6% (-90.6%/yr)LIMN -98.4% (-98.4%/yr)IMNN compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002026$9$2
IMNN LIMN

IMNN vs LIMN: by the numbers

  • •IMNN is the larger company ($5M vs $5M market cap).

Metrics side by side

Valuation

MetricIMNNLIMN
P/B ratio1.2417.31

Profitability

MetricIMNNLIMN
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-351.30%-4165.92%
ROIC-126.69%-225.12%

Growth (annualized)

MetricIMNNLIMN
Total return CAGR (5Y)-63.83%N/A

Go deeper

Full IMNN analysisFull LIMN analysisInteractive comparison tool

Dig into the metrics

Imunon ROELiminatus Pharma, Inc. Class A Common Stock ROEImunon operating marginLiminatus Pharma, Inc. Class A Common Stock operating marginImunon revenue growthLiminatus Pharma, Inc. Class A Common Stock revenue growthImunon free cash flowLiminatus Pharma, Inc. Class A Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.